Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: geek mirror

geek mirror

posted on Mar 25, 2007 09:15PM

 

 

Where professionals go for Internet Technology news

Next Inning Technology Research (http://www.nextinning.com), a subscription service focused on semiconductor and technology stocks, announced that it has changed its short-term outlook on Altera (Nasdaq: ALTR) due to a major event that has been underreported. Additionally, Editor Paul McWilliams has updated his outlooks on Transmeta (Nasdaq: TMTA), Intel (Nasdaq: INTC), and Patriot Scientific (OTC Bulletin Board: PTSC) and he also comments on Gartner's latest semiconductor sales prediction.


New subscribers will also receive the recently published 73-page Q4 State of Tech report, a $149 value, as well as all of McWilliams' earnings previews and reviews free when they sign up for a complimentary 30-day trial subscription to Next Inning:


https://www.nextinning.com/subscribe/index.php?refer=prn217


Here is a short sample: " ... the crowd has been slow to increase forecasts for semiconductor sales. Gartner, which in January predicted semiconductor sales would grow by only 7.6%, is starting to catch on, and is now expecting semiconductor sales to grow by 9.5%. We think that once the results for Q1 start flowing in April, or possibly even before then, we'll see a rush to jump onto our double-digit growth bandwagon."


McWilliams looked at these following topics, among others:


-- What led McWilliams to alter his short-term outlook for Altera and how does he think investors should handle the news?


-- What led McWilliams to flip from being a bear to a bull on Transmeta prior to the company's earnings release?


-- Is Intel attractively valued or will it have trouble growing due to its size?


-- After a 700% jump in price, what does McWilliams think about the value of Patriot Scientific?


Founded in September 2002, Next Inning's model portfolio has returned 297% since its inception versus 75% for the Nasdaq, and so far in 2006, it has returned 20.4%.


About Next Inning:


Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year industry veteran.


NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.


CONTACT: Rusty Szurek, Next Inning Technology Research, +1-888-278-5515

http://www.mirrorgeek.com/next-inning-technology-radically-changes-short-term-outlook-on-altera-due-to-a-major-underreported-event.html

Share
New Message
Please login to post a reply